Issue Date | Title | Author(s) | Source | scopus | WOS | Fulltext/Archive link |
---|---|---|---|---|---|---|
2017 | CCNE1 copy-number gain and overexpression identify ovarian clear cell carcinoma with a poor prognosis | Ayhan A.; Kuhn E.; Wu R.-C.; Ogawa H.; Bahadirli-Talbott A.; TSUI-LIEN MAO ; Sugimura H.; Shih I.-M.; Wang T.-L. | Modern Pathology | 41 | 40 | |
2009 | Cystic and adenofibromatous clear cell carcinomas of the ovary: Distinctive tumors that differ in their pathogenesis and behavior: A clinicopathologic analysis of 122 cases | Veras E.; TSUI-LIEN MAO ; Ayhan A.; Ueda S.; Lai H.; Hayran M.; Shih I.-M.; Kurman R.J. | American Journal of Surgical Pathology | 108 | 92 | |
2012 | Endocervical-type mucinous borderline tumors are related to endometrioid tumors based on mutation and loss of expression of ARID1A | Wu C.H.; TSUI-LIEN MAO ; Vang R.; Ayhan A.; Wang T.-L.; Kurman R.J.; Shih I.-M. | International Journal of Gynecological Pathology | 67 | 52 | |
2009 | Frequent activating mutations of PIK3CA in ovarian clear cell carcinoma | KUAN-TING KUO ; TSUI-LIEN MAO ; Jones S.; Veras E.; Ayhan A.; Wang T.-L.; Glas R.; Slamon D.; Velculescu V.E.; Kuman R.J.; Shih I.-M. | American Journal of Pathology | 382 | 339 | |
2015 | Immunohistochemical study of endometrial high-grade endometrioid carcinoma with or without a concurrent low-grade component: Implications for pathogenetic and survival differences | TSUI-LIEN MAO ; Ayhan A.; KUAN-TING KUO ; Lin M.-C.; LI-HUI TSENG ; Ogawa H. | Histopathology | 4 | 4 | |
2015 | Increased proliferation in atypical hyperplasia/endometrioid intraepithelial neoplasia of the endometrium with concurrent inactivation of ARID1A and PTEN tumour suppressors | Ayhan A.; TSUI-LIEN MAO ; Suryo Rahmanto Y.; Zeppernick F.; Ogawa H.; Wu R.-C.; Wang T.-L.; Shih I.-M. | Journal of Pathology: Clinical Research | 31 | 0 | |
2015 | Inhibition of Spleen Tyrosine Kinase Potentiates Paclitaxel-Induced Cytotoxicity in Ovarian Cancer Cells by Stabilizing Microtubules | Yu Y.; Gaillard S.; Phillip J.; TAI-CHUNG HUANG ; Pinto S.; Tessarollo N.; Zhang Z.; Pandey A.; Wirtz D.; Ayhan A.; Davidson B.; Wang T.-L.; Shih I.-M. | Cancer Cell | 101 | 100 | |
2013 | Loss of ARID1A expression correlates with stages of tumor progression in uterine endometrioid carcinoma | TSUI-LIEN MAO ; Ardighieri L.; Ayhan A.; KUAN-TING KUO ; Wu C.-H.; Wang T.-L.; Shih I.-M. | American Journal of Surgical Pathology | 81 | 78 | |
2012 | Loss of ARID1A expression is an early molecular event in tumor progression from ovarian endometriotic cyst to clear cell and endometrioid carcinoma | Ayhan A.; TSUI-LIEN MAO ; Seckin T.; Wu C.-H.; Guan B.; Ogawa H.; Futagami M.; Mizukami H.; Yokoyama Y.; Kurman R.J.; Shih I.-M. | International Journal of Gynecological Cancer | 135 | 120 |